A novel risk-scoring system conducing to chemotherapy decision for patients with pancreatic ductal adenocarcinoma after pancreatectomy
Yuqiang Li(Zhejiang Chinese Medical University), Cenap Güngör(Universität Hamburg), Xiangping Song(Central South University), Mengxiang Tian(Central South University), Lilan Zhao(Universität Hamburg), Christine Nitschke(Universität Hamburg), Daniel Pérez(Universität Hamburg), Wenxue Liu(Shanghai Jiao Tong University), Qian Pei(Central South University), Fengbo Tan(Central South University), Dan Wang(Breast Cancer Now), Yuan Zhou(Peking University)
Cited by 5
Related Papers
SRAMP: prediction of mammalian N<sup>6</sup>-methyladenosine (m<sup>6</sup>A) sites based on sequence-derived features
|Nucleic Acids Research|2016|1.2k
HMDD v3.0: a database for experimentally supported human microRNA–disease associations
|Nucleic Acids Research|2018|845
Trends in Diabetes Treatment and Control in U.S. Adults, 1999–2018
|New England Journal of Medicine|2021|684
Colorectal cancer cell-derived CCL20 recruits regulatory T cells to promote chemoresistance via FOXO1/CEBPB/NF-κB signaling
|Journal for ImmunoTherapy of Cancer|2019|231